Search results
Showing 616 to 630 of 877 results for community guidance
for life. Current clinical experience suggests that most patients in a community setting who are believed to be allergic to an oral...
numbers of patients dying with non-malignant diseases in hospitals and in community care. Anti-muscarinic agents may have undesired side...
Evaluation of these factors could be used to inform future NICE guidance, for example, specific guidance for management of...
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab (ESNM13)
Summary of the evidence on subcutaneous trastuzumab for HER2-positive breast cancer to inform local NHS planning and decision-making
complement the Care Act 2014, other associated care and support statutory guidance, and the Children and Families Act 2014. These set...
Function Classification System (GMFCS) level II or III result in good community mobility as a young adult? Any explanatory notes(if...
NICE has developed a medtech innovation briefing (MIB) on the S-Cath System for suprapubic catheterisations
Human growth hormone (somatropin) in adults with growth hormone deficiency (TA64)
Evidence-based recommendations on human growth hormone (somatropin; Genotropin, Humatrope, Norditropin, NutropinAq, Omnitrope, Saizen, Zomacton) for treating growth hormone deficiency in adults.
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.
This quality standard covers care and support for older people living in their own homes (known as home care or domiciliary care). It covers people aged over 65 using home care services, and may also cover some people under 65 with complex needs. It describes high-quality care in priority areas for improvement.
View quality statements for QS123Show all sections
Sections for QS123
- Quality statements
- Quality statement 1: Person-centred planning
- Quality statement 2: Plan for missed or late visits
- Quality statement 3: Consistent team of home care workers
- Quality statement 4: Length of home care visits
- Quality statement 5: Reviewing the outcomes of the home care plan
- Quality statement 6: Supervision of home care workers
- About this quality standard
This quality standard covers the initial management of self-harm and the provision of longer-term support for children and young people (aged 8 to 18) and adults (aged 18 and over) who self-harm. It describes high-quality care in priority areas for improvement.
View quality statements for QS34Show all sections
Sections for QS34
- Quality statements
- Quality statement 1: Compassion, respect and dignity
- Quality statement 2: Initial assessments
- Quality statement 3: Psychosocial assessments
- Quality statement 4: Observation
- Quality statement 5: Safe physical environments
- Quality statement 6: Care plans
- Quality statement 7: Psychological interventions
The STAK tool for preventing and treating knee stiffness (MIB252)
NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness .
Evidence-based recommendations on anakinra (Kineret) for treating adult-onset Still’s disease and systemic juvenile idiopathic arthritis in people 8 months and older.
This guideline covers the assessment, investigation and management of tinnitus in primary, community and secondary care. It offers advice to healthcare professionals on supporting people presenting with tinnitus and on when to refer for specialist assessment and management.
collaboration between the Hip Fracture Programme team, care-home staff and other community-based professionals and (2) a cluster...